Wells Fargo Sticks to Their Hold Rating for Clorox (CLX)
In a report released today, Christopher Carey from Wells Fargo maintained a Hold rating on Clorox, with a price target of $110.00.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Carey covers the Consumer Defensive sector, focusing on stocks such as Church & Dwight, Clorox, and Colgate-Palmolive. According to TipRanks, Carey has an average return of 1.4% and a 47.70% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Clorox with a $115.33 average price target.
Based on Clorox’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.67 billion and a net profit of $157 million. In comparison, last year the company earned a revenue of $1.69 billion and had a net profit of $193 million
Read More on CLX:
Disclaimer & DisclosureReport an Issue
- Clorox price target lowered to $110 from $121 at UBS
- Balanced Risk-Reward on Clorox: Limited Near-Term Upside Despite GOJO-Driven Revenue Boost and ERP-Inflated Growth Comparisons
- Clorox Completes Acquisition of Purell Maker GOJO Industries
- Clorox completes acquisition of Gojo Industries
- Clorox price target lowered to $98 from $111 at TD Cowen
